NCT00984620 - Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3) | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2011

Conditions

Hepatitis C

Interventions

DRUG

BI 201335

DRUG

BI 201335

DRUG

Pegylated Interferon-alpha (IFN)

Pegylated Interferon-alpha

DRUG

Ribavirin (RBV)

Trial Locations (28)

Unknown

1220.40.002 Boehringer Ingelheim Investigational Site, Tulepo

1220.40.007 Boehringer Ingelheim Investigational Site, New York

1220.40.006 Boehringer Ingelheim Investigational Site, Germantown

1220.40.004 Boehringer Ingelheim Investigational Site, Jackson

1220.40.003 Boehringer Ingelheim Investigational Site, Nashville

1220.40.005 Boehringer Ingelheim Investigational Site, Austin

1220.40.4303 Boehringer Ingelheim Investigational Site, Linz

1220.40.4301 Boehringer Ingelheim Investigational Site, Vienna

1220.40.1004 Boehringer Ingelheim Investigational Site, Calgary

1220.40.1001 Boehringer Ingelheim Investigational Site, Vancouver

1220.40.1002 Boehringer Ingelheim Investigational Site, Ottawa

1220.40.1003 Boehringer Ingelheim Investigational Site, Montreal

1220.40.1005 Boehringer Ingelheim Investigational Site, Montreal

1220.40.3303A Boehringer Ingelheim Investigational Site, Clichy

1220.40.3305A Boehringer Ingelheim Investigational Site, Lille

1220.40.3301A Boehringer Ingelheim Investigational Site, Marseille

1220.40.3306A Boehringer Ingelheim Investigational Site, Montpellier

1220.40.3302A Boehringer Ingelheim Investigational Site, Paris

1220.40.3304A Boehringer Ingelheim Investigational Site, Rennes

1220.40.4902 Boehringer Ingelheim Investigational Site, Berlin

1220.40.4909 Boehringer Ingelheim Investigational Site, Berlin

1220.40.4906 Boehringer Ingelheim Investigational Site, Düsseldorf

1220.40.4908 Boehringer Ingelheim Investigational Site, Düsseldorf

1220.40.4904 Boehringer Ingelheim Investigational Site, Hamburg

1220.40.4905 Boehringer Ingelheim Investigational Site, Mainz

1220.40.4001 Boehringer Ingelheim Investigational Site, Bucharest

1220.40.4002 Boehringer Ingelheim Investigational Site, Bucharest

1220.40.4003 Boehringer Ingelheim Investigational Site, Bucharest